MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients

Clinical Neuropathology
|February 1, 2020
PubMed
Abstract

Insights

MicroRNAs and HDAC4 protein show altered expression in the skeletal muscle of genetic Amyotrophic Lateral Sclerosis (ALS) patients, suggesting distinct disease mechanisms compared to sporadic ALS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease impacting motor neurons.
  • MicroRNAs are small regulatory molecules influencing gene expression post-transcriptionally.
  • Histone deacetylase 4 (HDAC4) plays a role in muscle pathophysiology and microRNA regulation.

Purpose of the Study:

  • To investigate microRNA expression in skeletal muscle of ALS patients.
  • To correlate microRNA levels with HDAC4 protein expression.
  • To differentiate pathogenic mechanisms in genetic versus sporadic ALS.

Main Methods:

  • Analysis of muscle biopsies from 18 ALS patients (genetic, sporadic, and upper motor neuron disease predominant).
  • Quantification of muscle-specific (miR-1, miR-133a/b, miR-206) and inflammatory microRNAs (miR-27a, miR-221, miR-155).
  • Western blotting to determine HDAC4 protein levels.

Main Results:

  • Genetic ALS cases showed significant upregulation of miR-206 and decreased HDAC4 protein.
  • miR-206 is implicated in neuromuscular junction function, regeneration, and muscle atrophy.
  • Increased inflammatory microRNAs were observed in genetic ALS patients.

Conclusions:

  • Distinct microRNA and HDAC4 expression patterns in genetic ALS suggest unique pathogenic pathways.
  • Findings highlight the potential role of specific microRNAs in ALS pathogenesis.
  • Differences observed between genetic ALS, sporadic ALS, and UMN disease cases warrant further investigation.